Raphael, A.;                     Salmon-Divon, M.;                     Epstein, J.;                     Zahavi, T.;                     Sonnenblick, A.;                     Shachar, S.S.    
        Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment. Genes 2022, 13, 1763.
    https://doi.org/10.3390/genes13101763
    AMA Style
    
                                Raphael A,                                 Salmon-Divon M,                                 Epstein J,                                 Zahavi T,                                 Sonnenblick A,                                 Shachar SS.        
                Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment. Genes. 2022; 13(10):1763.
        https://doi.org/10.3390/genes13101763
    
    Chicago/Turabian Style
    
                                Raphael, Ari,                                 Mali Salmon-Divon,                                 Jessica Epstein,                                 Tamar Zahavi,                                 Amir Sonnenblick,                                 and Shlomit S. Shachar.        
                2022. "Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment" Genes 13, no. 10: 1763.
        https://doi.org/10.3390/genes13101763
    
    APA Style
    
                                Raphael, A.,                                 Salmon-Divon, M.,                                 Epstein, J.,                                 Zahavi, T.,                                 Sonnenblick, A.,                                 & Shachar, S. S.        
        
        (2022). Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment. Genes, 13(10), 1763.
        https://doi.org/10.3390/genes13101763